High triglycerides/low high-density lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease

American Heart Journal

Volumn 145, Issue 1, 2003, Pages 103-108

  Jeppesen, Jørgen ^a   Hein, Hans Ole ^a,b   Suadicani, Poul ^a   Gyntelberg, Finn ^a  

^a Mental Health Services CPH   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE COURSE; ELECTROCARDIOGRAM; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT; STATISTICAL ANALYSIS; SURVIVAL RATE;

EID: 0037222132     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.45     Document Type: Article

References (37)

1. Reaven GM. Role of insulin resistance in human diseose. Diabetes 1988;37:1595-607.
2. Jeppesen J, Hein HO, Suadicani P, et al: Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease: An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997;17:1114-20.
3. Knutsen R, Knutsen SF, Curb JD, et al. The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program. J Clin Epidemiol 1988;41:293-302.
4. Sigurdsson E, Sigfusson N, Sigvaldason H, et al. Silent ST-T changes in an epidemiologic cohort study: A marker of hypertension or coronary heart disease, or both: The Reykjavik Study. J Am Coll Cardiol 1996;27:1140-7.
5. De Bacquer D, De Backer G, Kornitzer M, et al. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart 1998;80:570-7.
6. Jeppesen J, Hein HO, Suadicani P, et al. Triglyceride concentration and ischemic heart disease. Circulation 1998;97:1029-36.
7. Hein HO, Sørensen H, Suadicani P, et al. Alcohol consumption, Lewis phenotypes, and risk if ischaemic heart disease. Lancet 1993;341:392-6.
8. Hein HO, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol, and risk of ischaemic heart disease. BMJ 1996;312:736-41.
9. Siedel J, Klose S, Ziegenhorn J, et al. Improved reagent for the determination of serum cholesterol. J Clin Chem Biochem 1981;19:838-9.
10. Stahler F, Gruber W, Stinshoff K, et al. Eine praxis gerechte enzymatische Cholesterin-Bestimmung. Med Lab 1977;30:29-37.
11. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Lipid Res 1970;11:583-95.
12. Lopes-Virella MF. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-4.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Jeppesen J, Hein HO, Suadicani P, et al. Low triglycerides-high HDL cholesterol and risk of ischemic heart disease. Arch Intern Med 2001;161:361-6.
15. Rose GA, Blackburn H, Gillum RF, et al. Cardiovascular Survey Methods. 2nd Ed. Geneva: World Health Organization; 1982.
16. Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet 1964;1:296-300.
17. Suadicani P, Hein HO, Gyntelberg F. Serum cotinine validated form of smoking does not account for social inequalities in risk of ischaemic heart disease. Int J Epidemiol 1994;23:293-300.
18. Svalastoga K. Prestige, Class and Motility. Copenhagen: Munksgaard; 1959.
19. Madsen M, Balling H, Eriksen LS. The validity of the diagnosis of acute myocardial infarction in two Danish registers. Ugeskr Læger 1990;152:308-14.
20. Mosbech J, Jørgensen J, Madsen M, et al. The Danish National Patient Register: Evaluation of data quality. Ugeskr Læger 1995;157:3741-5.
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287;356-9.
22. Reaven GM, YD Chen, Jeppesen J, et al. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993;92:141-6.
23. Lahdenpera S, Tilly-Kiesi M, Vuorinen-Markkola H, et al. Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes. Diabetes Care 1993;16:584-92.
24. Carantoni M, Abbasi F, Warmerdam F, et al. Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler Thromb Vasc Biol 1998;18:762-7.
25. Steinberg D, Witztum JL. Lipoproteins and atherogenesis: Current concepts. JAMA 1990;264:3047-52.
26. Castelli WP. Epidemiology of triglycerides: A view from Framingham. Am J Cardiol 1992;70:3-9H.
27. Hodis HN, Mack WJ, Azen SP, et al. Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994;90:42-9.
28. Mack WJ, Krauss RM, Hodis HN. Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS), treatment effects and relation to coronary angiographic progression. Arterioscler Thromb Vasc Biol 1996;16:697-704.
29. Hamsten A, Wiman B, Defaire U, et al. Increased plasma level of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985;313:1557-63.
30. Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987;4:3-9.
31. Luria MH, Erel J, Sapoznikov D, et al. Cardiovascular risk factor clustering and ratio of total cholesterol to high-density lipoprotein cholesterol in angiographically documented coronary artery disease. Am J Cardiol 1991;67:31-6.
32. Nikkilä M, Koivula T, Niemelä K, et al. High density lipoprotein cholesterol and triglycerides as markers of angiographically assessed coronary artery disease. Br Heart J 1990;63:78-81.
33. Miranda CP, Lehmann KG, Froehlicher VF. Correlation between resting ST segment depression, exercise testing, coronary angiography, and long-term prognosis. Am Heart J 1991;122:1617-25.
34. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 1992;85:37-45.
35. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol: Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;34:410-8.
36. West of Scotland Coronary Prevention Group. West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet 1996;348:1339-42.
37. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998;279:1615-22.